XML 10 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 217,696 $ 319,589
Investment securities, available-for-sale 463,881 436,404
Accounts receivable, net 105,743 98,739
Interest and other receivables 7,971 5,956
Inventory 22,948 21,949
Prepaid expenses 52,703 55,681
Total current assets 870,942 938,318
Property and equipment, net 3,498 4,215
Operating lease right-of-use assets 50,614 46,571
Intangible assets, net 117,060 119,782
Restricted cash 8,770 8,770
Long-term inventory 80,025 69,741
Other assets 1,455 359
Total assets 1,132,364 1,187,756
Liabilities and stockholders’ equity    
Accounts payable 18,095 16,192
Accrued liabilities 284,435 378,678
Total current liabilities 302,530 394,870
Operating lease liabilities 44,634 42,037
Other long-term liabilities 19,963 18,056
Total liabilities 367,127 454,963
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024 0 0
Common stock, $0.0001 par value; 225,000,000 shares authorized at March 31, 2025 and December 31, 2024; 167,116,045 shares and 166,708,856 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 16 16
Additional paid-in capital 2,950,183 2,936,871
Accumulated deficit (2,185,399) (2,204,386)
Accumulated other comprehensive income 437 292
Total stockholders’ equity 765,237 732,793
Total liabilities and stockholders’ equity $ 1,132,364 $ 1,187,756